ASX:ANR

Anatara Lifesciences Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume3,950 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive ANR News and Ratings via Email

Sign-up to receive the latest news and ratings for Anatara Lifesciences and its competitors with MarketBeat's FREE daily newsletter.


About Anatara Lifesciences

Anatara Lifesciences Limited engages in the research and development of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans in Australia. Its lead product candidate includes Detach, a non-antibiotic therapy that prevents and treats diarrhea disease in piglets. The company is also developing bromelain formulations for gastrointestinal health in humans, as well as for piglets and poultry. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Anatara Lifesciences (ASX:ANR) Frequently Asked Questions

What stocks does MarketBeat like better than Anatara Lifesciences?

Wall Street analysts have given Anatara Lifesciences a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Anatara Lifesciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Anatara Lifesciences' next earnings date?

Anatara Lifesciences is scheduled to release its next quarterly earnings announcement on Monday, August 23rd 2021.
View our earnings forecast for Anatara Lifesciences
.

Who are Anatara Lifesciences' key executives?

Anatara Lifesciences' management team includes the following people:
  • Mr. Steven Lydeamore CPA, M.B.A., MBA, CPA, Chief Exec. Officer
  • Dr. Michael L. West, Chief Operating Officer (Age 57, Pay $296.83k)
  • Jane Lowe, Managing Director of IR Department
  • Dr. Stephen Denaro AGIA, BCom, GradDipApp CG, CA, MAICD, Company Sec.
  • Ms. Hayley van der Meer B Biomed Sc, Grad Dip Marketing Management, Commercial Mang.

Who are some of Anatara Lifesciences' key competitors?

What other stocks do shareholders of Anatara Lifesciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Anatara Lifesciences investors own include Woodside Petroleum (WPL), Temple & Webster Group (TPW), Brompton Oil Split (OSP), Eagle Materials (EXP), BHP Group (BHP) and Ameriprise Financial (AMP).

What is Anatara Lifesciences' stock symbol?

Anatara Lifesciences trades on the ASX under the ticker symbol "ANR."

How much money does Anatara Lifesciences make?

Anatara Lifesciences has a market capitalization of $0.00 and generates $268,259.00 in revenue each year.

What is Anatara Lifesciences' official website?

The official website for Anatara Lifesciences is www.anataralifesciences.com.

How can I contact Anatara Lifesciences?

The company can be reached via phone at 61 7 3394 8202.


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.